Latest Commercialization News

Omega Oil and Gas confirms the commercial viability of its Canyon Sandstone reservoir in Queensland’s Taroom Trough, with SLB modelling indicating nearly 1 million barrels of oil equivalent per well and significant upside potential.

IperionX secures a $12.5 million funding tranche from the U.S. Department of Defense to fast-track expansion of its Virginia titanium manufacturing capacity beyond 1,000 metric tons annually.

Big River Industries reported a 2.3% revenue decline for FY25 amid tough market conditions but achieved a notable rebound in the second half, driven by operational efficiencies and cost controls. The company maintains a strong balance sheet and a cautiously optimistic outlook for FY26.

Big River Industries reported a modest revenue decline in FY25 but achieved improved margins and operational efficiencies in the second half, positioning itself for growth as market conditions begin to stabilise.

Big River Industries reported a statutory net loss of $14.7 million for FY2025, driven by a $20 million impairment charge on intangible assets amid a 2.3% revenue decline. Despite the setback, the company declared a fully franked 2 cent dividend and showed signs of operational stabilization.

IVE Group Limited posted a robust FY25 marked by significant profit growth and margin expansion despite a slight revenue dip, while setting ambitious FY26 targets backed by strategic facility upgrades and sustainability progress.

Centrepoint Alliance has reported a robust FY25 financial performance, surpassing earnings guidance with a 16% rise in EBITDA and a 30% jump in pre-tax profits. The company also declared a 1.75 cent final dividend and advanced its technology and advisory services.

Johns Lyng Group reported a modest 1.8% revenue increase for FY25, driven by strong business-as-usual growth despite a steep decline in catastrophe-related income. The company’s FY26 forecast anticipates continued revenue expansion amid ongoing operational challenges.

Bio-Gene Technology Limited reported a net loss of AUD 2.58 million for FY2025 while making significant strides in developing its bio-insecticides Flavocide and Qcide, securing US Department of Defense grants and expanding global partnerships.

SPC Global reports stronger-than-expected FY25 results driven by international growth and synergy gains, while unveiling a new premium beverage division and a major lender transition.

Johns Lyng Group delivered steady FY25 financial results with revenue growth and strong core operations, while securing a $1.1 billion acquisition offer from Pacific Equity Partners.

Viva Energy's half-year results reveal a resilient Commercial segment offsetting pressures in Refining and Retail, as the company advances its retail transformation and cost synergy targets.